Disappointing monetary policy loosening from China, what’s jolting Apple’s suppliers, and more key earnings reports to come this week. Disappointing monetary policy loosening from China, what’s jolting Apple’s suppliers, and more key earnings reports to come this week. Disappointing monetary policy loosening from China, what’s jolting Apple’s suppliers, and more key earnings reports to come this week.

Disappointing monetary policy loosening from China, what’s jolting Apple’s suppliers, and more key earnings reports to come this week.

Equities 6 minutes to read
APAC Strategy Team

Summary:  China’s RRR cut and mixed economic reports remain underwhelming for the markets. Rising commodities and yields will remain the theme again this week, so brace for more volatility in stock and bond markets. Gold at an early stage of an uptrend, while yen’s underperformance will need more than a verbal intervention. Shanghai may be looking to restart production, but it will be patchy at best. IMF meetings to reflect increased central bank hawkishness.

What’s happening in markets?

Nasdaq 100 (USNAS100.I), S&P 500 (US500.I), China’s CSI300 and MSCI Asia Pacific ex Japan (FMASM2) – Asian markets followed the US stocks lower on Monday after the Good Friday holiday. Tech-heavy NASDAQ closed over 2% lower on Friday while S&P was down 1.2%. Some Asian markets like Hong Kong and Australia remain closed for Easter Monday, and most European markets will be on holiday as well. MSCI Asia Pacific ex-Japan (FMASM2) was down by 0.5% despite a positive surprise in China’s key economic data. Nikkei (NI225.I) was in loss of 1.8% amid losses in technology shares as inflation and rapid tightening concerns keep hold. CSI300 (000300.I) was down by 0.8% while Straits Times Index STI (ES3) was down by 0.5%.

China’s RRR cut underwhelms, Q1 GDP surprise insufficient to bolster sentiment. China's PBoC announced to reduce Reserve Requirement Ratio (RRR) by 0.25% which is estimated to increase the loanable fund in the Chinese banking system by RMB 530 billion. The market expected a bigger 0.50% cut. Q1 GDP data was mostly above expectations, even as consumption slumped and joblessness rose higher. Overall a strong headline Q1 GDP growth of 4.8% y/y still means that there is now a greater chance of the loan prime rate remaining unchanged on Wednesday or at most seeing a small 5 basis point cut. It reflects the fact that the authorities fear stoking another bubble in the property market while likely wanting credit policy to do much of the heavy lifting.

Crude oil (OILUKJUN22 & OILUSMAY22) continued to rise higher in Asia as supplies from Libya were interrupted and Russia warned of the potential for record prices if more nations ban its energy. WTI was close to the $108 handle and Brent remained around $113/barrel. The phased reopening of Shanghai is also bringing demand back on the table. Japan’s Inpex (1605) was up over 1.4%. Meanwhile, US natural gas reached fresh 13-year highs amid a de facto EU embargo on Russian gas. Gold (XAUUSD) also rose to a 5-week high and technical suggest an early stage of an uptrend.

What to consider?

Yen’s knee-jerk to Kuroda, but eyes remain on Yellen. USDJPY rose to fresh 20year highs of 126.79 on Monday as a dovish BOJ keeps local yields anchored to the floor while their U.S. equivalents surge on expectations for aggressive Fed hikes. BOJ Governor Kuroda’s described the yen’s recent drop being “very rapid” and cited a weaker yen has some negative effects on the economy, but no change in BOJ policy can still be expected and a weak yen remains positive for the economy. AUDJPY retreated towards 93.200 from day’s highs of 93.866 following China’s mixed data, and focus remains on Reserve Bank of Australia’s meeting minutes due on Tuesday.

Shanghai’s production resumption may kickstart manufacturing. Although reports of Shanghai’s first Covid fatalities in the current wave proved dire, business reopening plans supported sentiment as hopes of repairing the supply chains developed. Some of the firms that have been reported to be on the first version of a whitelist to restart according to state media reports are Fosun Pharma (600196), China Eastern Airlines (CEA). Tesla (TSLA) factories are also likely to resume production as early as this week.

Twitter’s (TWTR) poison pill means more volatility. Twitter adopted a poison pill to discourage hostile takeover attempts after Elon Musk’s unwelcome offer to take the company private. With Musk reportedly having a Plan B, and openly criticizing the management of Twitter, this means more volatility is in store. Tesla (TSLA) may be caught in the fire as well, but remains a medium to long-term story.

Trading ideas to consider

Fed Chair Powell may drop the final hint for a 50 basis point hike this week. Brace for more gains in yields and pain in tech stocks as Fed Chair Powell will be making his last public comments on Thursday at the IMF meetings before the Fed’s pre-meeting quiet period that starts Friday. He is expected to drop a final hint that a 50 basis points hike is coming and more details on quantitative tightening are also sought.

Apple suppliers in focus as China locks down key manufacturing areas. Lockdown in the entire Zhengzhou Airport Economic Zone, a manufacturing hub where Foxconn’s factories are located, due to rising COVID-19 cases is threatening iPhone production lines in China. Watch AAC Technologies (02018), Luxshare Precision (002475), GoerTek (002241).

Earnings due this week. Bank earnings continue with Bank of America (BAC) and BNY Mellon (BK) today and American Express (AXP) at the end of the week. We also get Pinnacle (PNFP), J&J (JNJ), Netflix (NFLX), IBM (IBM), Tesla (TSLA), BHP (BHP), United Airlines (UAL), AT&T (T), Keppel Corp (KPELY)  among many more this week.

Key Asian economic releases this week:

  • Tue, Apr 19: Japan industrial production, RBA meeting minutes
  • Wed, Apr 20: Japan March trade, China 1-year and 5-year loan prime rates
  • Thu, Apr 21: HK March unemployment rate
  • Fri, Apr 22: HK March CPI, RBI meeting minutes

For a global look at markets – tune into our Podcast. 


Saxo Capital Markets (Australia) Limited prepares and distributes information/research produced within the Saxo Bank Group for informational purposes only. In addition to the disclaimer below, if any general advice is provided, such advice does not take into account your individual objectives, financial situation or needs. You should consider the appropriateness of trading any financial instrument as trading can result in losses that exceed your initial investment. Please refer to our Analysis Disclaimer, and our Financial Services Guide and Product Disclosure Statement. All legal documentation and disclaimers can be found at https://www.home.saxo/en-au/legal/.

The Saxo Bank Group entities each provide execution-only service. Access and use of Saxo News & Research and any Saxo Bank Group website are subject to (i) the Terms of Use; (ii) the full Disclaimer; and (iii) the Risk Warning in addition (where relevant) to the terms governing the use of the website of a member of the Saxo Bank Group.

Saxo News & Research is provided for informational purposes, does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. No representation or warranty is given as to the accuracy or completeness of this information. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. No Saxo Bank Group entity shall be liable for any losses that you may sustain as a result of any investment decision made in reliance on information on Saxo News & Research.

To the extent that any content is construed as investment research, such content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication.

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments.Saxo Capital Markets does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo Capital Markets or its affiliates.

Please read our disclaimers:
- Full Disclaimer (https://www.home.saxo/en-au/legal/disclaimer/saxo-disclaimer)
- Analysis Disclaimer (https://www.home.saxo/en-au/legal/analysis-disclaimer/saxo-analysis-disclaimer)
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)

Saxo Capital Markets (Australia) Limited
Suite 1, Level 14, 9 Castlereagh St
Sydney NSW 2000

Contact Saxo

Select region


The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-au/about-us/awards

Saxo Capital Markets (Australia) Limited ABN 32 110 128 286 AFSL 280372 (‘Saxo’ or ‘Saxo Capital Markets’) is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms, Financial Services Guide, Product Disclosure Statement and Target Market Determination to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Saxo Capital Markets does not provide ‘personal’ financial product advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Capital Markets does not take into account an individual’s needs, objectives or financial situation. The Target Market Determination should assist you in determining whether any of the products or services we offer are likely to be consistent with your objectives, financial situation and needs.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website is not intended for residents of the United States and Japan.

Please click here to view our full disclaimer.